Profiel
Maureen Howard has been Vice President of Research for ChemoCentryx, Inc. since May 2001.
She was Vice President and Director of Research and Development for Corixa Corporation from April 1997 to May 2001 and a Founding Director of the Immunology Department at the DNAX Research Institute from January 1986 to April 1997.
Dr. Howard received a BS degree in Biochemistry from the University of Melbourne and a PhD in Immunology from the Walter and Eliza Hall Institute at the University of Melbourne, Australia.
Eerdere bekende functies van Maureen Howard
| Bedrijven | Functie | Einde |
|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Hoofd Techniek/Wetenschap/O&O | 01-05-2001 |
| DNAX Research, Inc. | Corporate Officer/Principal | 01-04-1997 |
| CHEMOCENTRYX, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Maureen Howard
| University of Melbourne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
| DNAX Research, Inc. |